Anzeige
Mehr »
Login
Samstag, 20.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: Voller Fokus auf NurExone Biologic!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0EAT9 | ISIN: BE0003818359 | Ticker-Symbol: GXE
Tradegate
19.04.24
21:55 Uhr
27,240 Euro
+0,080
+0,29 %
Branche
Biotechnologie
Aktienmarkt
BEL-20
AMX
1-Jahres-Chart
GALAPAGOS NV Chart 1 Jahr
5-Tage-Chart
GALAPAGOS NV 5-Tage-Chart
RealtimeGeldBriefZeit
27,02027,30013:04
27,06027,26019.04.

Aktuelle News zur GALAPAGOS NV Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.04.GALAPAGOS NV - 6-K, Report of foreign issuer1
04.04.Galapagos NV: Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024292Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) / Richter transformation (RT) Mechelen...
► Artikel lesen
01.04.Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst18
29.03.GALAPAGOS NV - 6-K, Report of foreign issuer2
28.03.Galapagos NV: Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders' Meetings472Publication of annual report for financial year 2023Annual Shareholders' Meeting resolutions include approval of revised Remuneration Policy and (re)appointment of Board membersExtraordinary Shareholders'...
► Artikel lesen
28.03.BofA downgrades Galapagos to Underperform over lack of catalysts in the near term13
26.03.Galapagos NV: Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board676Mechelen, Belgium; 26 March 2024, 21:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that during its meeting of 26 March 2024, the Board of Directors appointed Mr. Dickinson as Non-Executive...
► Artikel lesen
07.03.Morgan Stanley sets Galapagos stock at equalweight, $38 price target24
25.02.Earnings call: Galapagos reports solid financials, refines focus in R&D12
23.02.Galapagos halts lupus CAR-T program, confirms 100 layoffs so far this year25
23.02.GALAPAGOS NV - 6-K, Report of foreign issuer6
22.02.Frontier gets $80M, Galapagos' backing to make a better KRAS drug8
22.02.Galapagos NV: Galapagos announces full year 2023 results and outlook for 2024535Full year 2023 key financials: Group net revenues of €783.5 million, including Jyseleca® net sales of €112.3 million Cash and current financial investments of €3.7 billion on 31 December 2023Operational...
► Artikel lesen
21.02.Galapagos FY 2023 Earnings Preview10
20.02.Galapagos NV expected to post a loss of €1.18 a share - Earnings Preview13
20.02.Galapagos NV expected to post a loss of €3.93 a share - Earnings Preview8
16.02.GALAPAGOS NV - 6-K, Report of foreign issuer1
15.02.Galapagos NV: Galapagos presents at EBMT-EHA annual meeting 2024715Showcases meaningful advances in decentralized CAR T-cell manufacturing and presents translational and clinical data from ongoing Phase 1/2 CD19 CAR-T studies Mechelen, Belgium; 15 February 2024...
► Artikel lesen
08.02.EQS-News: Galapagos Biopharma Deutschland GmbH: Transaktion zur Übertragung des Jyseleca®-Geschäfts von Galapagos an Alfasigma für bis zu € 170 Millionen abgeschlossen - Galapagos Biopharma Germany GmbH unter neuer Flagge515EQS-News: Galapagos Biopharma Deutschland GmbH / Schlagwort(e): Firmenübernahme Transaktion zur Übertragung des Jyseleca®-Geschäfts von Galapagos an Alfasigma für bis zu € 170...
► Artikel lesen
06.02.GALAPAGOS NV - 6-K, Report of foreign issuer3
Seite:  Weiter >>
66 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1